Fetal hemoglobin induction during decitabine treatment of elderly high-risk MDS and AML patients: A potential dynamic biomarker for outcome

被引：0
|
作者：
Stomper, J. [1 ,2 ]
Ihorst, G. [2 ,3 ]
Suciu, S. [4 ]
Sander, P. N. [1 ,2 ]
Becker, H. [1 ,2 ]
Wijermans, P. W. [5 ]
Bisse, E. [2 ,6 ]
Claus, R. [1 ,2 ,7 ]
Luebbert, M. [1 ,2 ,8 ]
机构：
[1] Univ Freiburg, Fac Med, Dept Hematol Oncol & Stem Cell Transplantat, Freiburg, Germany
[2] Univ Freiburg, Med Ctr, Freiburg, Germany
[3] Univ Freiburg, Fac Med, Clin Trials Unit, Freiburg, Germany
[4] EORTC Headquarters, Brussels, Belgium
[5] Haga Hosp, Dept Hematol, The Hague, Netherlands
[6] Univ Freiburg, Fac Med, Inst Clin Chem & Lab Med, Freiburg, Germany
[7] Augsburg Med Ctr, Dept Internal Med 2, Hematol Oncol, Augsburg, Germany
[8] German Canc Res Consortium DKTK, Freiburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2018年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V90
引用
收藏
页码：19 / 19
页数：1
相关论文
共 50 条
  • [1] Fetal Hemoglobin (HbF) Induction during Initial Decitabine (DAC) Treatment of Elderly High-Risk MDS and AML Patients: A Potential Dynamic Biomarker for Outcome
    Stomper, Julia
    Ihorst, Gabriele
    Suciu, Stefan
    Sander, Philipp Nikolaus
    Becker, Heiko
    Wijermans, P. W.
    Bisse, Emmanuel
    Claus, Rainer
    Lubbert, Michael
    [J]. BLOOD, 2017, 130
  • [2] Fetal hemoglobin induction during decitabine treatment of elderly patients with high-risk myelodysplastic syndrome or acute myeloid leukemia: a potential dynamic biomarker of outcome
    Stomper, Julia
    Ihorst, Gabriele
    Suciu, Stefan
    Sander, Philipp N.
    Becker, Heiko
    Wijermans, Pierre W.
    Plass, Christoph
    Weichenhan, Dieter
    Bisse, Emmanuel
    Claus, Rainer
    Luebbert, Michael
    [J]. HAEMATOLOGICA, 2019, 104 (01) : 59 - 69
  • [3] Decitabine Plus Cytarabine for Induction of Remission in Newly Diagnosed Elderly AML or High Risk MDS Patients
    Gardner, Kelda
    Estey, Elihu H.
    Tong, Weigang
    McCroskey, Robert
    Walter, Roland B.
    Hendrie, Paul C.
    Scott, Bart L.
    Perdue, Andrea M.
    Percival, Mary-Elizabeth M.
    Smith, Heather A.
    Hammer, Cody
    Becker, Pamela S.
    [J]. BLOOD, 2016, 128 (22)
  • [4] A pilot study of bendamustine in elderly patients with high-risk MDS and AML
    Strupp, C.
    Knipp, S.
    Hartmann, J.
    Gattermann, N.
    Haas, R.
    Germing, U.
    [J]. LEUKEMIA & LYMPHOMA, 2007, 48 (06) : 1161 - 1166
  • [5] An inexpensive way to treat elderly patients with high-risk MDS or AML
    Kuendgen, Andrea
    [J]. LEUKEMIA RESEARCH, 2011, 35 (08) : 985 - 986
  • [6] Effects of decitabine, combined with all-trans retinoic acid or valproate, on fetal hemoglobin (HbF) induction in elderly AML patients
    Stomper, J.
    Bisse, E.
    Luebbert, M.
    [J]. ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 89 - 89
  • [7] Methylation Patterns of Fetal Hemoglobin Regulating Genes in High-Risk (HR) -MDS Patients Following Treatment with Azacytidinee
    Chatzilygeroudi, Theodora
    Chondrou, Vasiliki
    Athanasopoulou, Katerina
    Alexis, Spyridon
    Verigou, Evgenia
    Sgourou, Argyro
    Symeonidis, Argiris S.
    [J]. BLOOD, 2023, 142
  • [8] Copy number profiles of high-risk MDS and AML patients
    Ganster, C.
    Braulke, F.
    Shirneshan, K.
    Schanz, J.
    Neesen, J.
    Salinas-Riester, G.
    Platzbecker, U.
    Haase, D.
    [J]. ONKOLOGIE, 2013, 36 : 239 - 240
  • [9] Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS
    Janssen, Jeroen
    Lowenberg, Bob
    Manz, Markus
    Bargetzi, Mario
    Biemond, Bart
    Borne, Peter von Dem
    Breems, Dimitri
    Brouwer, Rolf
    Chalandon, Yves
    Deeren, Dries
    Efthymiou, Anna
    Gjertsen, Bjorn-Tore
    Graux, Carlos
    Gregor, Michael
    Heim, Dominik
    Hess, Urs
    Hoogendoorn, Mels
    Jaspers, Aurelie
    Jie, Asiong
    Jongen-Lavrencic, Mojca
    Klein, Saskia
    van der Klift, Marjolein
    Kuball, Jurgen
    van Lammeren-Venema, Danielle
    Legdeur, Marie-Cecile
    van de Loosdrecht, Arjan
    Maertens, Johan
    Kooy, Marinus van Marwijk
    Moors, Ine
    Nijziel, Marten
    van Obbergh, Florence
    Oosterveld, Margriet
    Pabst, Thomas
    van der Poel, Marjolein
    Sinnige, Harm
    Spertini, Olivier
    Terpstra, Wim
    Tick, Lidwine
    van der Velden, Walter
    Vekemans, Marie-Christiane
    Vellenga, Edo
    de Weerdt, Okke
    Westerweel, Peter
    Stussi, Georg
    van Norden, Yvette
    Ossenkoppele, Gert
    [J]. CANCERS, 2021, 13 (04) : 1 - 11
  • [10] Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine
    Jacobien R. Hilberink
    Isabelle A. van Zeventer
    Dana A. Chitu
    Thomas Pabst
    Saskia K. Klein
    Georg Stussi
    Laimonas Griskevicius
    Peter J. M. Valk
    Jacqueline Cloos
    Arjan A. van de Loosdrecht
    Dimitri Breems
    Danielle van Lammeren-Venema
    Rinske Boersma
    Mojca Jongen-Lavrencic
    Martin Fehr
    Mels Hoogendoorn
    Markus G. Manz
    Maaike Söhne
    Rien van Marwijk Kooy
    Dries Deeren
    Marjolein W. M. van der Poel
    Marie Cecile Legdeur
    Lidwine Tick
    Yves Chalandon
    Emanuele Ammatuna
    Sabine Blum
    Bob Löwenberg
    Gert J. Ossenkoppele
    Gerwin Huls
    [J]. Blood Cancer Journal, 13
12345